PRUNUS Therapeutics

Prenosis, based in Chicago, IL, is at the forefront of precision medicine in acute care, utilizing its Immunix™ platform to develop innovative diagnostic tools that enhance patient care. The Sepsis ImmunoScore™, the first FDA authorized AI diagnostic for sepsis, integrates biomarkers and clinical data to provide real-time insights and predictive outcomes for effective patient treatment. The company's mission is to empower healthcare providers by delivering a comprehensive understanding of each patient's biology, enabling tailored therapies that improve outcomes and drive down costs. With an expanding network of hospitals and a robust biobank, Prenosis is committed to reshaping the landscape of acute care through personalized medicine. Generated from the website

MicroMGx, Inc., based in Chicago, IL, is at the forefront of natural product discovery through its innovative MGx platform, which integrates metabolomics, genomics, and bioinformatics. The company aims to expedite the identification of novel natural products from microbial strains, ultimately providing access to groundbreaking agricultural and medicinal solutions. With a vision to enhance the rate of natural product discovery significantly, MicroMGx focuses on delivering valuable solutions for pharmaceutical and agricultural industries. Their pioneering approach, which includes the development of the MGX1001 herbicide, positions them as a leader in the quest for undiscovered compounds that can benefit global farmers and life sciences research. Generated from the website

Innopsys, Inc., located in Chicago, IL, is a specialist in microarray scanning technology, dedicated to providing innovative and reliable equipment and software for biotechnological medical research laboratories. With over 20 years of experience, the company combines cost-effectiveness with high performance to support advancements in life sciences research and diagnostics. Among their offerings are cutting-edge instruments like the InnoQuant whole slide fluorescence scanner and a variety of microarray scanners designed for cell and tissue analysis. Innopsys is committed to delivering state-of-the-art solutions that empower researchers in their pursuit of scientific discovery. Generated from the website